United States, Aug. 29 -- Today, leading up to the European Society of Cardiology (ESC) Congress 2025, GE HealthCare introduced its latest suite of cardiology innovations designed to enhance clinical decision-making, improve workflow efficiency, and support earlier diagnosis and treatment of cardiovascular disease (CVD)-the world's leading cause of death, responsible for an estimated 20.5 million deaths globally.GE HealthCare's cardiology care pathway offering - spanning screening, diagnosis, intervention, and follow-up - includes new AI-enhanced technologies that recently received CE mark and will be on display at ESC 2025:ViewPoint EchoPilot (TM) : This AI-powered workflow solution automates echo measurements and reporting, which can help...